| Targeted next‐generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS‐R A Tefferi, TL Lasho, MM Patnaik, L Saeed, M Mudireddy, D Idossa, ... American journal of hematology 92 (12), 1311-1317, 2017 | 95 | 2017 |
| Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer LA Huppert, O Gumusay, D Idossa, HS Rugo CA: a cancer journal for clinicians 73 (5), 480-515, 2023 | 91 | 2023 |
| Mutations and karyotype predict treatment response in myelodysplastic syndromes D Idossa, TL Lasho, CM Finke, RP Ketterling, MM Patnaik, A Pardanani, ... American journal of hematology 93 (11), 1420-1426, 2018 | 33 | 2018 |
| Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer: A real-world report from the cancer therapy using checkpoint inhibitors in people … T El Zarif, AH Nassar, E Adib, BG Fitzgerald, J Huang, TH Mouhieddine, ... Journal of Clinical Oncology 41 (21), 3712-3723, 2023 | 30 | 2023 |
| Infectious complications and malignancies arising after liver transplantation DW Idossa, DA Simonetto Anesthesiology Clinics 35 (3), 381-393, 2017 | 29 | 2017 |
| Influence of sociodemographic factors on treatment decisions in non–small-cell lung cancer N Duma, DW Idossa, U Durani, RD Frank, J Paludo, G Westin, Y Lou, ... Clinical lung cancer 21 (3), e115-e129, 2020 | 24 | 2020 |
| Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and … A Tefferi, D Idossa, TL Lasho, M Mudireddy, C Finke, S Shah, M Nicolosi, ... Blood cancer journal 7 (12), 658, 2017 | 24 | 2017 |
| Commentary: race and ethnicity in biomedical research–classifications, challenges, and future directions D Idossa, N Duma, K Chekhovskiy, R Go, S Ailawadhi Ethnicity & Disease 28 (4), 561, 2018 | 23 | 2018 |
| Abstract PS08-04: Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan … L Huppert, R Mahtani, S Fisch, N Dempsey, S Premji, A Raimonde-Taylor, ... Cancer Research 84 (9_Supplement), PS08-04-PS08-04, 2024 | 12 | 2024 |
| Protection of porcine endothelial cells against apoptosis with interleukin‐4 SM Black, BA Benson, D Idossa, GM Vercellotti, AP Dalmasso Xenotransplantation 18 (6), 343-354, 2011 | 9 | 2011 |
| ERBB2-low (also known as HER2-low) breast cancer D Idossa, M Borrero, A Blaes JAMA oncology 9 (4), 576-576, 2023 | 8 | 2023 |
| Policy and health: Leveraging a social determinants of health framework to alleviate the impact of the COVID-19 pandemic on patients with cancer HT Borno, D Idossa, SL Gomez JCO Oncology Practice 17 (3), 121-124, 2021 | 8 | 2021 |
| Cardiac melanoma: retrospective review of a rare disease at the Mayo clinic (1988–2015) CS Tse, N Tan, D Idossa, R Click International Journal of Cardiology 249, 383-386, 2017 | 8 | 2017 |
| Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients … LA Huppert, RL Mahtani, SC Fisch, N Dempsey, S Premji, A Taylor, ... Journal of Clinical Oncology 42 (16_suppl), 1083-1083, 2024 | 5 | 2024 |
| Case report: clinical characteristics and outcomes of HIV positive patients with metastatic prostate cancer treated with immunotherapy: A case series and literature review D Idossa, T Friedlander, CJ Paller, CJ Ryan, HT Borno Frontiers in Oncology 12, 910115, 2022 | 4 | 2022 |
| Mentorship experiences are not all the same: a survey study of oncology trainees and early-career faculty D Idossa, AI Velazquez, M Horiguchi, J Alberth, I Abuali, D Smith-Graziani, ... JCO oncology practice 19 (9), 808-818, 2023 | 3 | 2023 |
| 437 Safety and efficacy of immune checkpoint inhibitors (ICI) in patients living with HIV (PLWH) and metastatic non-small cell lung cancer (NSCLC): a matched cohort study from … T El Zarif, A Nassar, E Adib, B Fitzgerald, J Huang, T Mouhieddine, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 3 | 2022 |
| Where is your lactation room? Lactation policies and practices in oncology trainee and early career physicians. SJ Malapati, SRK Singh, D Idossa, X Jordan Bruno, F Chino, MA Patel, ... Journal of Clinical Oncology 40 (16_suppl), 11054-11054, 2022 | 3 | 2022 |
| Pulmonary Hypertension and Pericardial Effusions—To Tap or Not to Tap IY Shadrin, D Idossa, V Walston, J Lee, M Issa The American Journal of Medicine 133 (4), e149-e150, 2020 | 3 | 2020 |
| Ethnic and Racial Inequities in Cancer Screening During the COVID-19 Pandemic: a multi-site observational study in the United States D Idossa, HT Borno, K Wang, M Pletcher, G Gresham, AJ Canchola, ... International Journal of Cancer Care and Delivery 2 (2), 2022 | 2 | 2022 |
